首页> 外国专利> DISCOVERY OF NOVEL ANTI-INFECTIVES FOR GRAM NEGATIVE PATHOGENS

DISCOVERY OF NOVEL ANTI-INFECTIVES FOR GRAM NEGATIVE PATHOGENS

机译:发现革兰阴性病原体的新型抗感染性

摘要

Burkholderia pseudomallei (Bp) and Burkholderia mallei (Bm) are Tier-1 select pathogens that cause highly lethal human infections with limited therapeutic options. Intercellular spread is a hallmark of Burkholderia pathogenesis and its prominent ties to virulence make it an attractive therapeutic target. We developed a high-throughput cell-based phenotypic assay and screened ˜220,000 small molecules for their ability to disrupt intercellular spread by Burkholderia thailandensis, a BSL-2 surrogate for these pathogens. 268 hits were identified, and cross-species validation found 32 hits that also disrupt intercellular spread by Bp and/or Bm. In a fulminant murine model of respiratory melioidosis, treatment with a number of these agents was significantly more effective than ceftazidime, the current drug of choice, for improving patient survival and decreasing bacterial counts in major organs.
机译:Burkholderia Pseudomallei(BP)和Burkholderia Mallei(BM)是Tier-1选择病原体,导致具有有限的治疗选择的高度致命人类感染。 细胞间传播是伯克德利菌的标志性发病机制,其与毒力的突出关系使其成为有吸引力的治疗目标。 我们开发了一种基于高通量的细胞的表型测定,并筛选〜220,000个小分子,用于扰乱Burkholderia泰国人的细胞间涂抹的能力,该病原体的BSL-2替代剂。 确定了268次命中,并发现跨物种验证32个命中,也扰乱了BP和/或BM的细胞间传播。 在呼吸兴美疾病的过度鼠模型中,许多这些试剂的治疗比CEFTAZIDIME,目前的首选药物显着更有效,用于改善主要器官中的患者存活率和降低细菌计数。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号